Could ETQ's share price be soon to benefit from their developments with the new UVGI Nightingale Mobile Air Filtration Product.

New UVGI air filtration product

In November 2002, the ETQ announced its new Nightingale UVGI air filtration product, to be produced by a new joint-venture company, UVGI Systems Limited, owned 55% by the Group and 45% by Suvair Limited. This rapid response mobile air filtration unit is capable of killing the MRSA super bug and other airborne pathogens.

The UVGI unit has widespread application where there is need to keep
air free of dangerous live bacteria, viruses, and fungal spores, including
hospitals, schools, cruise liners, aircraft, food processing, and military
applications.

The UVGI unit uses a high intensity Ultra Violet Germicidal Irradiation ('UVGI')
filter, which has been designed to control harmful and dangerous airborne
pathogens, such as Anthrax, Tuberculosis, and Staphylococcus aureus, the
causative agent in MRSA. The filtration system is combined with use of high
intensity Ultra Violet light, which inactivates micro organisms by disrupting
their DNA structure.

Tests of a prototype at the Defence Science Technology Laboratory ('Dstl') at
Porton Down, the centre for excellence for the Ministry of Defence, showed that
the UVGI unit captured and/or destroyed more than 99.9% of Bacillus subtilis
spores, a simulant for Anthrax bacteria.

Since November, second generation units have been developed, which will go on
applications testing at an NHS Trust Hospital in December 2003, following
building completion of its new haematology unit. It is also anticipated the
UVGI unit will shortly go on laboratory testing in the United States with
contractors nominated by the Department of Homeland Security.

Concern seems to be hotting up on the T.V. news that the MRSA super bug is still killing and disabling people visiting or as patients in NH Trust hospitals. It would be surprising if NH Trust hospital do not notice and Buy this product before they get to many expensive law suits for compensation claims.

Definitely a stock that could soon be heading north. Worth buying in but DYOR

L.

RELATED NEWS LINKS

Sky News Sun 28th Sept 03 - NEW ANTIBIOTICS WARNING
BBC World News Thurs 4th December 03 - Hospital infections: Case studies
BBC World News Fri 5th Dec 03 - 'Superbug' crackdown is launched
BBC World News Monday 22nd Dec 03 - Superbugs lurk in intensive care
Sky News Sun 14th Dec 03 - SUPERBUG CARRIED BY PETS
BBC World News Thurs 26th Feb 04 - Superbug deaths increase 15-fold
BBC World News Mon 22nd March 04 - MRSA superbug hits more children
BBC World News Fri 2nd April 04 - Superbug outbreak in cardiac ward
BBC World News Thurs 8th April 04 - NHS faces superbug legal claims
BBC World News Sun 6th June 04 - Government 'complacent' over MRSA
BBC World News Fri 18th June 04 - Superbug deaths 'set to double'
BBC World News Thurs 1st July 04 - Holland's tough line combats MRSA
BBC World News Thurs 1st July 04 - Overcrowded hospitals breed MRSA
ITV.com Fri 9th July 04 - Mother's MRSA nightmare
ITV.com Fri 9th July 04 - 'MRSA superbug has done this to me'
ITV.com Fri 9th July 04 - Precautions you can take against MRSA
Sky News Sun 11th July 04 - WAR DECLARED ON MRSA
BBC UK News Mon 12th July 04 - Drive to fight hospital superbugs

apple read the RNS - Here I will help you

S O L D

SOLD/BOUGHT/CUSTOMER HAS PAID MONEY

Kapiche ?

Regardless of your old bit of news your stuburness has made yourself lose an awaful amount of potential money !

Happy1

Don't start personal attacks just be happy that you can get some of your money back.

I guess from your posts since January that you need more than 10p to get all your money back.

Good luck!

Yep, I missed a nice big spike but we can all say that with hindsight.
A hindsight of a temporary speculative spike.

It has already fallen back & I will be very surprised if it gets to 10p within a year.

Be happy with your recent gains on SPS, you picked a very good one there!

Not personal just annoyed with your ramblings. No I am sitting on free shares having sold out at 15p keeping the profit in stock ;-)

Hold on wave 2

Wednesday July 7, 04:31 PM

Related Quotes
Energy Technique PLC
ETQ.L
6.25
+2.25

More on Yahoo! Finance
The Latest Share Tips
Breaking Financial News
Mortgage Advice
Insurance Quotes

Energy Technique makes strong gains on upbeat product news
Energy Technique (LSE: ETQ.L - news) shares were up by 56.3 per cent at 6.3p in late trade in London on Wednesday after it announced the sale of its first Nightingale air filtration system - designed to kill the hospital superbug MRSA, TB and other dangerous germs - to the US healthcare system.

The company said the sale strengthened its case for the product to be used in the NHS.

Click here for more from FT.com

London & Boston has a is a big share holder in Energy Techniquesee see details below. Have a look at L&B web site it seems to be moving in the right direction at last.

Energy Technique Plc


In accordance with the Companys enhancement policy, London & Boston organised a consortium (including Harrell, the Chairman of Rotch, a company connected with the family of Geoffrey Dart and London & Boston) to invest 1.1m for 50.2% of Energy Technique, which has a full listing on the London Stock Exchange. The investment was completed on 15 June 2001. At that time London & Boston invested 230,354 in cash and 182,000 by the issue to Energy Technique of 1,820,000 Existing Ordinary Shares of 2p each in London & Boston at 10p each in exchange for the issue to London & Boston of ordinary shares in Energy Technique representing approximately 18.81% of Energy Techniques share capital plus options over a further 4% of this company exercisable within 5 years. Geoffrey Dart resigned as chairman of the company and Graham Mackenzie was appointed. Stephen Komly remains the senior non-executive director.

First established in 1879, Energy Technique specialises in the design, manufacture and distribution of high quality air conditioning and heating products. With an impressive customer list, including the Houses of Parliament, Nat West, HSBC and Barclays Banks, Marks & Spencer, Land Securities and Hilton hotels, The Savoy and Claridges hotels. The company has developed a high tech, energy saving, air conditioning system called the Ambassador System for commercial and hotel use. The consortium has brought and will continue to bring new introductions and business opportunities to expand Energy Techniques core Diffusion business.

The company has caused considerable excitement due to its innovative development of a system which removes all known airborne pathogens. The Company won the Fastest Moving Share Award for 2002 rising to 30p per share at one point from the 3p at which London & Boston arranged the re-financing of the company in June 2001

Well a retractment was expected.

Now time to add further.

TODAYS FINANCIAL TIMES mentions ENERGY TECHNIQUE as one of the SHINERS of last week stating that with the USA deal the UK deals with the NHS should follow due to this breakthrough! Give this a few more months and this should be at a reasonable level. The pattern so far has been like TADPOLE and YOOMEDIA a doubling of shareprice with a slight dip back and then onwards with more deals no doubt. We should see 20p within months I reckon -good luck all that are in!!

Author Chis Lines View Profile | Add to favourites | Ignore
Date posted today 12:24
Classification Press info
Subject: WAR DECLARED ON MRSA
Recommendations This message has not been recommended
Message

There is no mention of ETQ in these reports but lets hope the government decides to employ new technology rather than just 'spin'


http://www.sky.com/skynews/article/0,,30000-1142573,00.html

http://politics.guardian.co.uk/publicservices/story/0,11032,1258831,00.html

Mention in the Evening Standard and again in the FT

Energy Technique and Bioquell, both working on products to combat the hospital superbug MRSA, were up 16.5 per cent at 8p and 1.6 per cent at 160p respectively after the UK government unveiled its own plans to combat the spread of the infection

Just tipped by City Equities in their July newsletter !

RNS Number:9188A
Energy Technique PLC
16 July 2004


Energy Technique plc ("the Company")


Holding in Company


The Company was notified on 15 July 2004 by Insinger de Beaufort that it has an
interest in 14,314,444 ordinary shares of 1p each in the Company, representing
9.57 per cent of the current issued share capital of the Company.


16 July 2004






This information is provided by RNS
The company news service from the London Stock Exchange

END
HOLZGGMNGVGGDZM

ETQ is starting to look interesting. Keeping an eye on these.

Todays's News of the World Newspaper:

EXCLUSIVE: Ridding hopsitals of MRSA isn't rocket science Mr Blair..just try cleaning them


MRSA hospital disgrace



By Melanie Swan and David McGee

THIS is the disgusting, grime-infested sight that appalled a frantic dad when he took his three-day-old baby to an MRSA-infected hospital for surgery.

The 35-year-old father rushed his son Alexander to St George's Hospital in Tooting, south-west London hoping doctors would reassure him about the baby's bowel problem.

But he ended up fearing for the tot's life when he realised medics would OPERATE on his child in the filthy room, with its blood-stained floor strewn with used dressing packets and dirty swabs.

Doctors surgically removed a small piece of tissue from Alexander's lower intestine for testing, using invasive surgery which could have exposed him to deadly MRSA.

Syringes

"It was a disgrace," said the engineer from south London, who does not wish to be named.

His pictures reinforce our campaign for Tony Blair to wipe out MRSAwhich kills up to 20,000 people each yearby making sure hospitals are kept clean. They show:

Used NEEDLES on chairs yards from baby Alexander's incubator

A BLOOD-STAINED bedside cabinet

Thick DIRT on the child's life-saving intravenous drip machinery.

The tot's furious dad added: "This dirt was so thick I could scrape it off. I couldn't believe these were the conditions supposed to be curing my son.

"Used bits of equipment were all over the place, including syringes on seats. And to top it all, the blood on the floor had footprints going through it. Staff just shrugged when I asked about it. I asked for a cleaner to come and it took six hours. But the dirt on the intensive care machine was never cleaned up.

"The z-bed we were given to stay on overnight had holes in it with stuffing falling out. And there was something that could only be described as old blood dripping down a cabinet."

St George's Healthcare Trust is ranked the 11th most infected by MSRA among specialist hospitals in Britain. It had 93 cases last year.

We showed the shocking photographs to News of the World columnist Dr Hilary Jonesand he spelled out just how lucky baby Alexander was to have survived the ordeal unscathed.

Grimy

"These pictures appear to show grimy intravenous equipment, stains on the floor potentially harbouring micro-organisms and even blood on incubators," he said.

"Bacteria hazards build up and include infections such as pneumonia, meningitis and septicaemia, which has a 20 per cent mortality rate. One of the major causes of death in tiny babies is infection.

"We're seeing more cases of MRSA in paediatric wards than ever before. Conditions need to be absolutely sterile to reduce the risk of infection."

St George's spokesman Paul Spindler said: "Specialist hospitals have many cases involving invasive treatment, which make them more susceptible to infections such as MRSA.

"We try to maintain the highest standards of cleanliness and will be looking into your story very closely as a way of learning any lessons."

Bug plan is not enough

PLANS to tackle the deadly MRSA superbug don't go far enough, say the News of the World's Patients' Panel.

Health Secretary John Reid has vowed to give patients bedside hotlines to cleaners, increase ward inspections and give nursing chiefs more powers.

But pensioner panellist Alf, who picked up MRSA during a heart op several years ago, says: "There need to be more isolation wards to contain the bug. And hospital staff need more training."

Mum Diana, who has a diabetic seven-year-old son,said: "Every time I walk into the hospital I worry he might pick up something.

"I hope this isn't all just more hot air from the government."

Tanker driver Steven, 42, suffers from heart disease and says nurses must fully embrace the measures if we are to stamp out the threat.

Mum-of-three Anna, 32, who has breast cancer, says: "If the hotline is to work there has to be immediate action."

Final Patients' Panellist, pregnant trainee teacher Susan, 33, said: "My baby is due in six months but I'll be terrified if we don't get results by then."

Our undercover panel of five patients is monitoring the NHS to see whether Tony Blair is delivering his health promises.

Nearly ready to buy into these, siginificant retreat from highs of 8 pence three weeks ago, current price : 5.00-5.75 pence. Waiting now to see if the price holds at this level, if it does, I am in.

Looks like I was right again about spikes in this stock.

This was just another spike.

The fundementals don't support the share price & the price of the current product is too high.

This company can be a winner if it uses the technology in big air con system but that may not happen til next year.

Hi apple, I think the price dropping back was due to their results which were announced last week for the period ending 31 March 2004.

Release after Market close today :

RNS Number:2342B
Energy Technique PLC
26 July 2004


Energy Technique plc ("the Company")

Holding in Company

Further to the RNS released on 16 July 2004 under RNS No 9188A, the Company
wishes to clarify that the announcement made on 16 July 2004 was incorrect and
should have identified Triandra Limited and not Insinger de Beaufort, as
interested in 14,314,444 Ordinary Shares in the Company.

The notification followed sales from Triandra Limited between 8 July 2004 and 12
July 2004, which reduced its holding from 17,064,444 to 14,314,444 Ordinary
Shares. Accordingly, Triandra Limited's interest in the current issued share
capital of the Company fell from 11.4 per cent. to 9.57 per cent. on 12 July
2004.

26 July 2004



This information is provided by RNS
The company news service from the London Stock Exchange

END
HOLFGGZNVVKGDZM

RNS Number:0578B
Energy Technique PLC
21 July 2004


Energy Technique plc
Preliminary Announcement 2004


* #3 million share placing to finance growth of the new high-value divisions

* First sale of UVGI Nightingale system in the USA in July 2004,following
successful completion of testing by the Health Protection Agency

* Diffusion Heating and Cooling sales recovery in third quarter in competitive
market

* Diffusion DX Air Conditioning sales up from #0.8 million to #2.6 million

* Exclusive EU distribution rights obtained for NQ Environmental ultra violet
products to complement the Group's Nightingale UVGI unit

* Exclusive EU distribution rights obtained from Nutech of Canada

Overview
Following a year of extremely difficult operating conditions caused by a sharp
and unexpected downturn in the Group's traditional markets, I am pleased to be
able to report that we have now put in place both the funding and new
distribution agreements needed to develop and grow the new Diffusion Air
Treatment division and Diffusion DX Air Conditioning.

I am pleased to report that a #3 million share placing was completed on 30 April
2004, which has re-financed the Group and will provide the necessary capital
base to fund the planned growth of the Group. In the first quarter of the
current financial year, Diffusion Heating and Cooling continued its recovery.


Current trading and prospects

The group incurred a small loss in the first quarter of the year ending 31 March
2005, due primarily to operating losses incurred by Diffusion Air Treatment:

* Diffusion Heating and Cooling slightly exceeded its expected sales
levels, but only managed to break even, due to a combination of weaker than
expected sales mix and margin. Importantly, Diffusion Heating and Cooling
generated operating profits in both May and June and has good trading
prospects for the second quarter.

* Diffusion DX Air Conditioning operated close to its expected sales and profit
levels and the forward order prospects are excellent.

* The operating losses for Diffusion Air Treatment were lower than expected,
due to a combination of sales below expectations offset by lower operating
costs. The investment in additional resources could not be started until the
proceeds of the #3 million share placing were received in early May, but
investment in development and marketing of the new product ranges is now
proceeding as fast as is feasible.

The Group is now soundly financed, following completion of the #3 million share
placing and the Board is now confident of realising its full potential over the
next 24 months.


Group financial performance in the year ended 31 March 2004

Group sales fell from #11.7 million to #10.8 million and an operating loss after
exceptional items was incurred of #1.472 million.

Diffusion Heating and Cooling sales fell to #8.0 million (2003: #10.9 million),
due to a sharp deterioration in the fan coil market in the first half of 2003.
The division incurred an operating loss for the first time in many years of
#196,000 before exceptional items (2003: profit of #883,000).

Diffusion DX Air Conditioning sales grew strongly in its second year of
operation to #2.6 million (2003: #0.8 million for eight months trading). The
division incurred a reduced operating loss of #124,000 (2003: #258,000) as sales
moved further towards the projected sales targets.

Diffusion Air Treatment generated initial sales of Lifebreath products of
#182,000. The division incurred an operating loss of #338,000 due to start up
losses on Lifebreath, combined with engineering and development costs associated
with the Nightingale UVGI unit.

Central costs rose to #311,000 (2003: #256,000), due to the additional costs
incurred during the long-term illness of Stephen McNeice.

Exceptional redundancy costs were incurred by Diffusion Heating and Cooling of
#75,000 in the first quarter of the financial year.

An exceptional loss was incurred on the disposal of the Company's investment in
the shares of London and Boston Investments of #311,000.

Group cash flow

The group incurred a cash outflow of #869,000 (2003: inflow of #209,000) due
primarily to the operating losses incurred. Investment in stocks and debtors
increased due to the higher sales volumes achieved in the fourth quarter,
compared with the previous year. As a result of the cash outflow from operating
activities, capital expenditure was contained at #33,000 (2003: #142,000).

In February 2004, the Company sold its entire investment in the shares of London
and Boston Investments plc for #203,000, at a price of 4 pence per share. This
followed a prolonged period when the share price had been around or below the
price achieved.

The accounts include a pro-forma balance sheet at 31 March 2004, showing the
impact on the audited balance sheet as if the #3 million share placing proceeds
had been received on that date. This pro-forma balance sheet shows a net
positive bank position of #896,000.


Dividends

The Board does not recommend the payment of a dividend (2003: nil).


Operations
Diffusion Heating and Cooling ("Diffusion HC")

Diffusion HC experienced its worst year of trading for many years. The market
for fan coils and commercial heating products took a sudden and sharp downturn
in the first half of 2003 due to the uncertainty created by the global political
and economic situation at the time of the Iraq war. From a low point in the
first quarter of #1.524 million, sales subsequently recovered for the remainder
of the year to reach #8.0 million for the full year. This was significantly
down on the previous year's sales of #10.9 million.

As a result, for the first time in many years, Diffusion HC incurred an
operating loss of #196,000, before an exceptional charge for redundancies of
#75,000. A redundancy programme was completed in May 2003 involving 25 staff,
adjusting the cost base down to expected reduced sales volumes. The operating
loss was incurred in the first half year. Diffusion HC made a small profit in
the second half year on the increased sales volumes experienced. A dominant
feature of the current market place is the much shorter order lead times
demanded by contractors, which have adversely affected manufacturing
efficiencies due to the lateness in receiving final manufacturing instructions.

Diffusion HC's fan coils and heating products have continued to feature in many
prestigious office and hotel developments during the year, including The London
Stock Exchange, Scottish Parliament, Aspreys New Bond Street, Esso Glen Building
2, Standard Life, Lloyds TSB, HM Treasury, B & Q, and MBR Whitehall. The award
winning and patented Ambassador hotel fan coil unit gained further accolade from
the City Inn Westminster Hotel, where the external design team were successful
in winning the Best New Hotel Award at the recent European Hotel and Design
Conference 2003.

Diffusion HC continues to re- position itself by growing its commercial heating
product range, reducing reliance on fan coil sales. The commercial heating
product range is mid-way through an update programme and sales management
changes have been effected. The benefits of this strategy are expected to show
through in the latter part of the current financial year.


Diffusion DX Air Conditioning ("Diffusion DX")

Diffusion DX is now in its second year of operation and is becoming much more
established in the market place as a distributor of Panasonic and LG Electronics
packaged air conditioning equipment. This division continued to rapidly grow
during the year, with sales of #2.6 million, achieving excellent progress
towards reaching the annual sales targets set when the operation was first set
up in August 2002.

Diffusion DX moved into operating profit in the quarter ended 30 September 2003,
but incurred losses during the winter months, due to the traditionally seasonal
nature of the packaged air conditioning sector. Much marketing effort is being
directed towards larger value project led work, so as to reduce the seasonal
nature of this business.

The division's product offering was significantly enhanced in January 2004, when
Diffusion DX was granted distributor status for the Fujitsu range of packaged
air conditioning equipment. Diffusion DX is now in a strong position in the
market place as a distributor for three leading manufacturer's air conditioning
products. The Board is confident the addition of Fujitsu will enable
achievement of our objective for Diffusion DX to become one of the leading
distributors for the estimated #300 million UK market for packaged air
conditioning equipment.

Diffusion Air Treatment ("Diffusion AT")

The Diffusion AT division was formed in November 2003 to coordinate the Group's
activities in developing the air treatment and energy efficiency markets. This
division offers two product ranges:

* The Nightingale UVGI unit and NQ Environmental Inc's range of ultrab violet
products treat and sanitise air containing harmful airborne pathogens
such as TB, SARS and MRSA.

* The Lifebreath product range supplies fresh air ventilation to domestic homes
to manage the airtight construction methods required by new UK building
regulations.

Nightingale and NQ Environmental

In November 2002, the Company announced the prototype of its new Nightingale
unit and in April 2003 it won the Air Movement Product of The Year Award at the
2003 HVAC industry's H & V awards. During 2003, a second-generation production
model of the Nightingale unit was developed, and the accreditation test of this
production model, carried out at the Health Protection Agency, has now been
successfully completed.

The Group is in advanced discussions with a leading European manufacturer of air
handling plant to jointly develop a duct-mounted version of the Nightingale unit
and also to act as exclusive distributor of the Nightingale unit in Scandinavia.

The Board has identified the need to offer a wider range of products using ultra
violet technology in addition to the premium priced, high specification
Nightingale unit. The Group has therefore entered into an exclusive
distribution agreement with the American company, NQ Environmental Inc., to
distribute a complete range of low to medium specification ultra violet air
treatment products in the UK and elsewhere in the European Union. NQ
Environmental has supplied its products to approximately 700 hospitals,
predominantly in the USA and Canada and has a distribution agreement with Owens
and Minor Inc, the largest US medical equipment distribution company, to
distribute products throughout the USA.

NQ has been granted a period of exclusivity to 30 September 2004, to enable it
to explore opportunities for marketing the Nightingale unit in the US and
Canadian markets. The Nightingale was exhibited by NQ at a commercial trade
show in the USA in June where interest was very encouraging. The initial sale
in the USA of product using Nightingale technology was achieved in July 2004 to
the Northwest Hospital Center in Randallstown, Maryland.

Lifebreath

The Group has established an exclusive agreement with the Canadian company,
Nutech, to distribute its Lifebreath range of products in the UK, and elsewhere
in the European Union and Switzerland. Lifebreath products are filtration and
heat recovery systems targeted primarily at the domestic home market. The
products are capable of complying with building regulations by providing fresh
air ventilation (helpful for asthma, hay fever and other allergies caused by
poor air quality) to offset airtight construction methods and at the same time
recovering up to approximately 70% of normal heating energy loss.

The first Lifebreath sales in the UK were made in the year ended 31 March 2003.
A sales team has now been recruited and prospects for rapid growth are
excellent.

Directors

Robert Unsworth was re-appointed to the Board on 1 July 2003 as an executive
director, responsible for finance and company secretarial matters whilst Stephen
McNeice remains on long term sick leave. The Board wishes him a speedy
recovery.

Management and employees

On behalf of the Board, I should like to thank all employees for their continued
hard work, loyalty and commitment during the difficult trading conditions last
year.

Graham R Mackenzie
Chairman


Group profit and loss account
for the year ended 31 March 2004
2004 2003
Note #000 #000

Turnover 3 10,819 11,704
Cost of sales (8,508) (7,884)

Gross profit 2,311 3,820
Distribution costs (2,466) (2,388)
Administrative expenses (889) (1,063)


Operating (loss)/profit
Before exceptional items 3 (969) 369
Exceptional items 4 (75) -

(Loss)/profit before interest (1,044) 369
Loss on disposal of fixed asset investment 4 (311) -
Interest payable (117) (106)

(Loss)/profit on ordinary activities before taxation (1,472) 263

Tax on (loss)/profit on ordinary activities - -

(Loss)/profit for the financial year (1,472) 263
Dividends on equity shares - -

Transfer (from)/to reserves (1,472) 263

Earnings/(loss) per share:
Basic 5 (2.01)p 0.36p
Diluted 5 (2.01)p 0.31p
Before exceptional items 5 (1.48)p 0.36p

Both the turnover and operating results shown above are entirely in respect of
continuing operations.

There are no other recognised gains or losses other than as recorded in the
profit and loss account for the year.


Group balance sheet
At 31 March 2004 31 March 31 March
2004 2003
#000 #000
Fixed assets
Intangible assets 17 -
Tangible assets 317 401
Investments - 514
334 915
Current assets
Stocks 1,323 1,040
Debtors 2,654 2,153
Cash at bank - 186
3,977 3,379
Creditors - amounts falling due within one year (4,515) (2,949)

Net current (liabilities)/assets (538) 430

Total assets less current liabilities (204) 1,345

Creditors - amounts falling due after more than one year (7) (129)

(211) 1,216

Capital and reserves
Called up share capital 746 731
Share premium account 1,587 1,557
Other reserves 7,449 7,449
Profit and loss account (9,993) (8,521)

Equity shareholders' funds (211) 1,216

Note:

The group was re-financed with a #3 million share placing completed on 30 April
2004. A pro-forma balance sheet showing the impact of this share placing at 31
March 2004 is set out on page 12.


Reconciliation of movements in shareholders' funds
For the year ended 31 March 2004

Group
2004 2003
#000 #000

(Loss)/profit for the year (1,472) 263
Issue of ordinary shares 15 -
Increase in share premium account 30 -

Movements in shareholders' funds (1,427) 263

Shareholders' funds at beginning of year 1,216 953

Shareholders' funds at end of year (211) 1,216



Group cash flow statement 2004 2003
For the year ended 31 March 2004
#000 #000

Cash (outflow)/inflow from operating (905) 487
activities
Returns on investment and servicing of (117) (106)
finance
Capital expenditure and financial investment (33) (142)
Expenditure on intangible assets (17) (30)
Disposal of shares in London & Boston
Investments plc 203 -

Cash (outflow)/inflow before financing (869) 209
Financing:
Issue of share capital 45 -
Increase in debt 638 14
(Reduction)/increase in cash during year (186) 223


Reconciliation of net cash flow to movement in net debt
2004 2003
#000 #000

(Reduction)/increase in cash in year (186) 223
Increase in debt (638) (14)

Change in net debt resulting from cash flows (824) 209
New finance leases - (26)

(Increase)/reduction in net debt (824) 183
Net debt at start of year (947) (1,130)

Net debt at end of year (1,771) (947)


Reconciliation of operating profit to operating cash flows

2004 2003
#000 #000
Operating (loss)/profit before exceptional (969) 369
items
Exceptional items (75) -

Operating (loss)/profit after exceptional (1,044) 369
items
Depreciation and amortisation 117 149
Stocks (283) (316)
Debtors (501) 487
Creditors 806 (202)
(905) 487

Notes to the accounts

1. Accounting policies

The financial information set out above has been prepared using accounting
policies consistent with 2003.

2. Basis of preparation

The financial information for the year ended 31 March 2004 and 2003 set out
above does not constitute statutory accounts within the meaning of section 240
of the Companies Act 1985. The information has been extracted from the
statutory accounts of Energy Technique plc for the year ended 31 March 2004,
which have not yet been filed with the Registrar of Companies. Statutory
accounts for the year ended 31 March 2003 have been delivered to the Registrar
of Companies. Statutory accounts for the year ended 31 March 2004 were approved
by the Board of Directors on 20 July 2004, are audited and will be delivered to
the Registrar of Companies following the Annual General Meeting on 6 October
2004.

The Company's auditors, Milsted Langdon, have reported on the 2004 and 2003
accounts under section 235(1) of the Companies Act 1985. Those reports were not
qualified within the meaning of section 235(2) of the Companies Act 1985 and did
not contain statements made under section 237(2) and 237(3) of the Companies Act
1985.

3. Segmental analysis

Turnover Operating profit/ Operating net
(loss) assets
2004 2003 2004 2003 2004 2003
#000 #000 #000 #000 #000 #000
Diffusion Heating and Cooling

Before exceptional items 7,994 10,930 (196) 883 - -
Redundancy costs - - (75) - - -

After exceptional items 7,994 10,930 (271) 883 1,130 1,409
Diffusion DX Air Conditioning 2,643 774 (124) (258) 476 326
Diffusion Air Treatment 182 - (338) - 37 -
Central and Plc costs

Before exceptional items - - (311) (256) - -
Sale of unlisted investment - - (311) - - -

After exceptional items - - (622) (256) (83) 428
10,819 11,704 (1,355) 369 1,560 2,163

Borrowings (1,771) (947)
Taxation - -
(211) 1,216

4. Exceptional items
2004 2003
#000 #000
Operating items
Redundancies and employee termination costs 75 -
Loss on disposal of shares in London and Boston Investments plc 311 -
386 -

The exceptional items have been classified as follows:
Cost of sales 75 -
Loss on disposal of fixed asset investment 311 -
386 -
The tax effect of exceptional items is to increase trading and capital losses
carried forward.

5. (Loss)/earnings per share

The (loss)/earnings per share calculations have been arrived at by reference to
the following earnings and weighted average number of shares in issue during the
year.
2004 2003
#000 #000
Basic
(Loss)/profit after tax (1,472) 263

Before exceptional items
Operating (loss)/profit (969) 369
Interest payable (117) (106)
Tax payable - -

(Loss)/profit after tax (1,086) 263

No. No.
Weighted average number of shares in issue 73,337,751 73,075,456
Weighted average number of shares on a diluted basis 83,612,779 84,828,723

Supplementary basic (loss)/earnings per share have been calculated to exclude
the effect of redundancy costs and the loss on the disposal of the Company's
investment in the shares of London and Boston Investments plc.

6. Posting of Report and Accounts

The 2004 Report and Accounts will be posted to shareholders on 28 July 2004.

Contacts:

Allan Piper, First City Financial Public Relations: 020 7436 7486
07050 203304

Graham Mackenzie, Chairman, Energy Technique plc: 07901 550577

Leigh Stimpson, Managing Director, Energy Technique plc: 07919 214882

Rob Unsworth, Finance Director, Energy Technique plc: 020 8783 0033


Pro-forma balance sheet
At 31 March 2004
31 March Adjustment for 31 March
2004 Share 2004
Audited Placing Pro-forma
#000 #000 #000
Fixed assets
Intangible assets 17 - 17
Tangible assets 317 - 317
334 - 334
Current assets
Stocks 1,323 - 1,323
Debtors 2,654 - 2,654
Cash at bank - 928 928
3,977 928 4,905
Creditors - amounts falling due within one year
Borrowings (1,764) 1,739 (25)
Other creditors (2,751) - (2,751)
(4,515) 1,739 (2,776)
Net current (liabilities)/assets (538) 2,667 2,129
Total assets less current liabilities (204) 2,667 2,463
Creditors - amounts falling due after more than one year
Borrowings (7) - (7)

(211) 2,667 2,456

Capital and reserves
Called up share capital 746 750 1,496
Share premium account 1,587 1,917 3,504
Other reserves 7,449 - 7,449
Profit and loss account (9,993) - (9,993)

Equity shareholders' funds (211) 2,667 2,456


The pro-forma balance sheet shown above has been extracted from the audited
balance sheet at 31 March 2004, adjusted only for the impact of the #3 million
share placing completed on 30 April 2004, net of estimated costs of #333,000.
No adjustments have been made for trading since 31 March 2004 or for any other
adjustments.


This information is provided by RNS
The company news service from the London Stock Exchange
END

TA (Technical Analyis is looking good after today's close at these prices) :

Investtech Analysis after today's close :

Positive Candidate (Short term) - Jul 26, 2004
Is within an approximate horizontal trend, which indicates further development in the same direction. The stock has support at p 4.30 and resistance at p 8.00. Volume tops and volume bottoms correspond well with tops and bottoms in the price. This strengthens the stock and increases the chance of a break up. Trading volume has increased substantially lately. This shows there is an increased interest for the stock, possibly because of fundamental news. The stock is overall assessed as technically positive for the short term.

Positive Candidate (Medium term) - Jul 26, 2004
ENERGY TECH. ORD 1P has broken the falling trend and reacted strongly up. For the time being, it is difficult to say anything about the future trend direction. The stock has resistance at p 8.70. The RSI curve shows a rising trend, which could be an early signal for the start of a rising trend. The stock is overall assessed as technically positive for the medium long term.

Neutral (Long term) - Jul 26, 2004
Has broken the falling trend down, which indicates an even stronger falling rate. Has reacted back after the break of the inverse head and shoulders formation. There is support around 3.79, which now indicates good buying opportunities. An established break through this support will neutralize the positive signal. The stock has support at p 2.70 and resistance at p 11.20. Volume tops correspond well with price tops, and volume bottoms correspond well with price bottoms. Volume balance is also positive, which weakens the falling trend and could be an early signal for a coming trend break. Trading volume has increased substantially lately, which may be because of fundamental news. The stock is overall assessed as technically neutral for the long term.

Promising :

---------The RSI curve shows a rising trend, which could be an early signal for the start of a rising trend.

---------Volume balance is also positive (i.e. more buying than selling), which weakens the falling trend and could be an early signal for a coming trend break.